Antiproliferative action of cyclic GMP-elevating vasodilators in cultured rabbit aortic smooth muscle cells

Atherosclerosis. 1989 Dec;80(2):143-7. doi: 10.1016/0021-9150(89)90022-1.

Abstract

In cultured rabbit aortic smooth muscle cells (SMCs), sodium nitroprusside (SNP) (10(-7) to 10(-4) M), atrial natriuretic peptide (ANP) (10(-9) to 10(-6) M) and 8-bromo-cyclic GMP (10(-6) to 10(-3) M) inhibited the whole blood serum (WBS)-induced DNA synthesis by about 30%. The doses of SNP and ANP necessary for the inhibition of the WBS-induced DNA synthesis were similar to those necessary for the formation of cellular cyclic GMP (cGMP). These agents were effective even when added 6 h after stimulation of the cells with WBS. These results suggest that cGMP inhibits the proliferation of rabbit aortic SMCs by inhibiting the progression from the G1 into S phase of the cell cycle and raise the possibility that cGMP-elevating vasodilators may suppress the atherogenic process by inhibiting vascular SMC proliferation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Aorta / drug effects
  • Atrial Natriuretic Factor / pharmacology*
  • Cell Division / drug effects
  • Cells, Cultured
  • Cyclic GMP / analogs & derivatives*
  • Cyclic GMP / pharmacology
  • Cyclic GMP / physiology*
  • DNA / biosynthesis
  • Ferricyanides / pharmacology*
  • In Vitro Techniques
  • Muscle, Smooth, Vascular / drug effects*
  • Nitroprusside / pharmacology*
  • Rabbits
  • Vasodilator Agents / pharmacology*

Substances

  • Ferricyanides
  • Vasodilator Agents
  • Nitroprusside
  • 8-bromocyclic GMP
  • Atrial Natriuretic Factor
  • DNA
  • Cyclic GMP